* Biote Corp BTMD.OQ BTMD.O is expected to show a rise
in
quarterly revenue when it reports results on November 12 for
the period ending September 30 2024
* The Irving Texas-based company is expected to report a
12.8% increase in revenue to $51.384 million from $45.56 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Biote Corp is for
earnings of
9 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Biote Corp
is
9.94, above its last closing price of $5.56.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 0.08 0.09 -0.15 Missed -273.1
Mar. 31 2024 0.03 0.03 -0.06 Missed -280
Dec. 31 2023 0.08 0.08 0.18 Beat 134.8
Sep. 30 2023 0.08 0.08 0.24 Beat 220
Jun. 0.09 0.10 -0.25 Missed -363.2
30 2023
Mar. 31 2023 0.09 0.09 -0.39 Missed -533.3
Dec. 31 2022 0.14 0.18 Beat 28.6
Sep. 30 2022 0.14 0.14 -1.74 Missed -1,388
.9
This summary was machine generated November 9 at 00:59 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)